Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

Oliver, S. E., Gargano, J. W., Marin, M., Wallace, M. M., Curran, K. G., Chamberland, M. E., McClung, N. M., Campos-Outcalt, D. E., Morgan, R. L., Mbaeyi, S. A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6950e2 · Cited by 536

Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Rüggeberg, J. U., Gold, M., Bayas, J. M., Blum, M. D., Bonhoeffer, J., Friedlander, S. F., Brito, G. D. S., Heininger, U., Imoukhuede, E. B., Khamesipour, A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.064 · Cited by 383

Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity — United States, January 26–October 3, 2020

Rossen, L. M., Branum, A. M., Ahmad, F. B., Sutton, P., & Anderson, R. N. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6942e2 · Cited by 373

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Shimabukuro, T. T., & Nair, N. (2021) · JAMA · doi:10.1001/jama.2021.0600 · Cited by 327

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020

Oliver, S. E., Gargano, J. W., Marin, M., Wallace, M. M., Curran, K. G., Chamberland, M. E., McClung, N. M., Campos-Outcalt, D. E., Morgan, R. L., Mbaeyi, S. A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm695152e1 · Cited by 317

Vaccine-associated hypersensitivity

McNeil, M. M., & Destefano, F. R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.971 · Cited by 274

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021

CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7004e1 · Cited by 270

From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era

Miao, G., Chen, Z., Cao, H., Wu, W., Chu, X., Liu, H., Zhang, L., Zhu, H., Cai, H., Lu, X., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114208 · Cited by 27

What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later

Copaescu, A. M., Duque, J. S. R., & Phillips, E. J. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.03.030 · Cited by 24

Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines

Mouri, M., Imamura, M., Suzuki, S., Kawasaki, T., Ishizaki, Y., 櫻井恵一, Nagafuchi, H., Matsumura, N., Uchida, M., Ando, T., et al. (2022) · Allergology International · doi:10.1016/j.alit.2022.05.007 · Cited by 24

Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink

Blumenthal, K. G., Phadke, N. A., & Bates, D. W. (2021) · JAMA · doi:10.1001/jama.2021.14808 · Cited by 26

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system

Chapin-Bardales, J., Myers, T., Gee, J., Shay, D. K., Marquez, P., Baggs, J., Zhang, B., Licata, C., & Shimabukuro, T. T. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.019 · Cited by 23

Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital.

Vigezzi, G. P., Lume, A., Minerva, M., Nizzero, P., Biancardi, A., Gianfredi, V., Odone, A., Signorelli, C., & Moro, M. (2021) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v92is6.12217 · Cited by 24

Exacerbation of branch retinal vein occlusion post SARS-CoV2 vaccination

Tanaka, H., Nagasato, D., Nakakura, S., Tanabe, H., Nagasawa, T., Wakuda, H., Imada, Y., Mitamura, Y., & Tabuchi, H. (2021) · Medicine · doi:10.1097/md.0000000000028236 · Cited by 23

ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine

Yadav, R., Shah, S., & Chhetri, S. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104123 · Cited by 23

COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)

Chary, M. A., Barbuto, A. F., Izadmehr, S., Tarsillo, M., Fleischer, E., & Burns, M. M. (2023) · Journal of Medical Toxicology · doi:10.1007/s13181-023-00931-9 · Cited by 25

Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems

Li, J., Zhang, Y., Yang, Y., & Sun, T. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00276 · Cited by 24

COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society

Ku, C. R., Jung, K. Y., Ahn, C. H., Moon, J. S., Lee, J. H., Kim, E. H., Kwon, H., Kim, H. K., Suh, S., Hong, S., et al. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.404 · Cited by 22

Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services

Top, K. A., Chen, R. T., Levy, O., Ozonoff, A., Carleton, B., Crawford, N. W., Creech, C. B., Kochhar, S., Poland, G. A., Gutu, K., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac407 · Cited by 22

Sex-Differential and Non-specific Effects of Vaccines Over the Life Course

Clair, L. A. S., Chaulagain, S., Klein, S. L., Benn, C. S., & Flanagan, K. L. (2023) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-35139-6_9 · Cited by 24

The mRNA vaccine, a swift warhead against a moving infectious disease target

Mir, S., & Mir, M. A. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2024.2320327 · Cited by 28

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concernPreprint

Fiolet, T., Kherabi, Y., MacDonald, C. J., Ghosn, J., & Peiffer‐Smadja, N. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/z4x7t · Cited by 22

The adverse reactions to vaccines practice parameter 10 years on—what have we learned?

Kelso, J. M. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.01.026 · Cited by 21

Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years

Lloyd, P. C., Hu, M., Wong, H., Shoaibi, A., Zhou, C. K., Lo, A., Amend, K. L., Beachler, D. C., McMahill‐Walraven, C. N., Smith, E. R., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.09.060 · Cited by 21

The Importance of Gender-Sensitive Health Care in the Context of Pain, Emergency and Vaccination: A Narrative Review

Graf, J., Simoes, E., Kranz, A., Weinert, K., & Abele, H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21010013 · Cited by 25

Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience

Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T., & Weldon, D. (2021) · Allergy and Asthma Proceedings · doi:10.2500/aap.2021.42.210069 · Cited by 20

COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021

Hwang, I., Park, K., Kim, T. E., Kwon, Y., & Lee, Y.-K. (2021) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2021.0310 · Cited by 20

Rapid progress in our understanding of COVID-19 vaccine allergy: A cause for optimism, not hesitancy

Banerji, A., Norton, A. E., Blumenthal, K. G., Stone, C. A., & Phillips, E. J. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.03.023 · Cited by 20

Safety of Global SARS-CoV-2 Vaccines, a Meta-Analysis

Chen, L., Cai, X., Zhao, T., Han, B., Xie, M., Cui, J., Zhang, J., Wang, C., Liu, B., Lu, Q., et al. (2022) · Vaccines · doi:10.3390/vaccines10040596 · Cited by 20

Side Effects of the COVID-19 Vaccines

Dumitru, I. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105668 · Cited by 20

Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines–Early experience with vaccine rollout in a multi-site healthcare system

Al‐Obaydi, S., Hennrikus, E. F., Mohammad, N., Lehman, E. B., Thakur, A., & Al‐Shaikhly, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272691 · Cited by 20

The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample

Barnes, K., Faasse, K., & Colagiuri, B. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.023 · Cited by 20

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2

Jamous, Y. F., & Alhomoud, D. A. (2023) · Cureus · doi:10.7759/cureus.45602 · Cited by 24

COVID-19

Marks, K., & Gulick, R. M. (2023) · Annals of Internal Medicine · doi:10.7326/aitc202310170 · Cited by 21

Estimating Baseline Incidence of Conditions Potentially Associated with Vaccine Adverse Events: a Call for Surveillance System Using the Korean National Health Insurance Claims Data

Huh, K., Kim, Y., Radnaabaatar, M., Lee, D. H., Kim, D. W., Shin, S., & Jung, J. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e67 · Cited by 20

A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink

Yih, W. K., Daley, M. F., Duffy, J., FIREMAN, B. H., McClure, D. L., Nelson, J. C., Qian, L., Smith, N. X., Vazquez‐Benitez, G., Weintraub, E., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.12.026 · Cited by 21

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose

Tuong, L.-A. C., Capucilli, P., Staicu, M. L., Ramsey, A. C., Walsh, E. E., & Mustafa, S. S. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab507 · Cited by 19

COVID-19 mRNA vaccine allergy

Risma, K. (2021) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001077 · Cited by 21

Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System

Crisafulli, S., Cutroneo, P. M., Luxi, N., Fontana, A., Ferrajolo, C., Marchione, P., Sottosanti, L., Zanoni, G., Moretti, U., Franzè, S., et al. (2023) · Drug Safety · doi:10.1007/s40264-023-01277-5 · Cited by 19

COVID-19 Vaccination in Korea

Park, W. B., Hwang, Y. H., & Cheong, H. J. (2023) · Infection and Chemotherapy · doi:10.3947/ic.2023.0023 · Cited by 19

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data

van den Ouweland, F., Charpentier, N., Türeci, Ö., Rizzi, R., Mensa, F., Lindemann, C., & Pather, S. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2315659 · Cited by 20

COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers

Famuyiro, T., Ogunwale, A. N., Bordes, J. D., & Raji, M. A. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01093-6 · Cited by 19

Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination

Amiya, S., Fujimoto, J., Matsumoto, K., Yamamoto, M., Yamamoto, Y., Yoneda, M., Kuge, T., Miyake, K., Shiroyama, T., Hirata, H., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.01.031 · Cited by 18

Management of suspected and confirmed COVID ‐19 ( SARS‐CoV ‐2) vaccine hypersensitivity

Worm, M., Alexiou, A., Bauer, A., Treudler, R., Wurpts, G., Dickel, H., Buhl, T., Müller, S., Jung, A., Brehler, R., et al. (2022) · Allergy · doi:10.1111/all.15414 · Cited by 18

High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data

Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., Sah, R., & Tanimoto, T. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab090 · Cited by 17

COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan

Singh, B., Kaur, P., Kumar, V., & Maroules, M. (2021) · Radiology Case Reports · doi:10.1016/j.radcr.2021.04.053 · Cited by 17

The Waiver of Patent Protections for COVID-19 Vaccines During the Ongoing Pandemic and the Conspiracy Theories: Lights and Shadows of an Issue on the Ground

Nioi, M., & Napoli, P. E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.756623 · Cited by 16

Vaccine against COVID-19

Picazo, J. J. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/085.2021 · Cited by 22

Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland

Paczkowska, A., Hoffmann, K., Michalak, M., Hans-Wytrychowska, A., Bryl, W., Kopciuch, D., Zaprutko, T., Ratajczak, P., Nowakowska, E., & Kus, K. (2022) · Vaccines · doi:10.3390/vaccines10030434 · Cited by 17

Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers

Wi, Y. M., Kim, S., & Peck, K. R. (2021) · Vaccines · doi:10.3390/vaccines9080931 · Cited by 16

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions

Pitlick, M. M., Sitek, A. N., D’Netto, M. E., Dages, K. N., Chiarella, S. E., Gonzalez‐Estrada, A., Joshi, A. Y., & Park, M. A. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.11.006 · Cited by 16

Discrete polyethylene glycol derivatives as a potent impetus for next-generation biomedicines

Cen, J., Hou, M., & Liu, S. (2023) · Giant · doi:10.1016/j.giant.2023.100169 · Cited by 16

SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systemic review and meta-analysis

Sung, K., Chang, T.-E., Wang, Y., Lin, C., Chang, C., Hou, M., & Lu, C. (2022) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000682 · Cited by 16

Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance

Stehlin, F., Aljedani, R. M., Canton, L., Monzambani, V., Miauton, A., Girard, C., Kammermann, K., Meylan, S., Ribi, C., Harr, T., et al. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.818049 · Cited by 17

mRNA vaccines against COVID‐19: a showcase for the importance of microbial biotechnology

Brüssow, H. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13974 · Cited by 16

Sex Differences in Adverse Reactions to an Inactivated SARS-CoV-2 Vaccine Among Medical Staff in China

Zhu, J., Zhang, M., Chien, C.-W., Yang, W., Shi, G., Qiu, S., Tung, T., & Chen, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.731593 · Cited by 16

COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol

Patel, G. B., Chhiba, K. D., Chen, M. M., Guo, A., Watts, M. M., Cullen, J., Bochner, B. S., Grammer, L. C., Greenberger, P. A., Saltoun, C. A., et al. (2021) · Allergy and Asthma Proceedings · doi:10.2500/aap.2021.42.210075 · Cited by 15

CoronaVac/Sinovac COVID-19 Vaccine-Related Hypersensitivity Reactions and Second-Dose Vaccine Administration: Tertiary Allergy Center Experience

Gümüşburun, R., Dalgıç, C. T., Mete, N., & Sin, A. Z. (2022) · International Archives of Allergy and Immunology · doi:10.1159/000524099 · Cited by 15

Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea

Kim, S., Hwang, I., Ko, M., Kwon, Y., & Lee, Y.-K. (2022) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2022.0122 · Cited by 14

COVID-19 vaccines: Frequently asked questions and updated answers

Lefebvre, M., Vignier, N., Pitard, B., Botelho-Nevers, É., Wyplosz, B., Cohen, R., & Épaulard, O. (2021) · Infectious Diseases Now · doi:10.1016/j.idnow.2021.02.007 · Cited by 16

Forewarned is forearmed: chronic spontaneous urticaria as a potential risk to effective SARS‐CoV‐2 vaccine uptake and global public health

Bermingham, W. H., Ardern‐Jones, M. R., Huissoon, A. P., & Krishna, M. T. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20495 · Cited by 15

COVID-19 Vaccine Anaphylaxis: Current Evidence and Future Approaches

Laisuan, W. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.801322 · Cited by 15

Anaphylaxis and Related Events Following COVID‐19 Vaccination: A Systematic Review

Paul, P., Janjua, E., Al-Subaie, M., Ramadorai, V., Mushannen, B., Vattoth, A. L., Khan, W., Bshesh, K., Nauman, A., Mohammed, I., et al. (2022) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2120 · Cited by 15

SARS-CoV-2 Vaccines and the Skin

Galván‐Casas, C., Català, A., & Muñoz‐Santos, C. (2021) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2021.07.028 · Cited by 14

Significance of digestive symptoms after COVID-19 vaccination: A retrospective single-center study

Lee, D. S., Kim, J. W., Lee, K. L., Jung, Y. J., & Kang, H. W. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.05.044 · Cited by 14

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report

McDonnell, J. C., Cousins, K. L., Younger, M. E. M., Lane, A., Abolhassani, H., Abraham, R. S., Al‐Tamemi, S., Aldave-Becerra, J. C., Al-Faris, E. H., Alfaro-Murillo, A., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01613-5 · Cited by 14

Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines

Moro, P. L., & McNeil, M. M. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2019020 · Cited by 14

SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center

Tanno, L. K., Bérard, F., Beaudoin, É., Didier, A. P., & Demoly, P. M. (2021) · Vaccines · doi:10.3390/vaccines9060560 · Cited by 13

Hypersensitivity Reactions to Vaccines: Current Evidence and Standards for SARS-CoV-2 Vaccines

Carvalho, J. C., Cunha, F., Coutinho, I. A., Loureiro, C., Faria, E., & Todo‐Bom, A. M. (2021) · Acta Médica Portuguesa · doi:10.20344/amp.16096 · Cited by 12

Anaphylaxis to additives in vaccines

Mahler, V., & Junker, A. (2022) · Allergo Journal International · doi:10.1007/s40629-022-00215-8 · Cited by 13

COVID-19 vaccinations in German pharmacies: A survey on patient and provider satisfaction

Rose, O., Erzkamp, S., Schöbel, W., Grajeda, M., & Köberlein–Neu, J. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.07.034 · Cited by 13

COVID-19 Vaccination in Cancer Patients: A Review Article

Mekkawi, R., Elkattan, B., Shablak, A., Bakr, M., Yassin, M. A., & Omar, N. E. (2022) · Cancer Control · doi:10.1177/10732748221106266 · Cited by 13

Polyethylene Glycol Allergy and Immediate-Type Hypersensitivity Reaction to COVID-19 Vaccination: Case Report

Habran, M., Vandebotermet, M., & Schrijvers, R. (2021) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0740 · Cited by 12

Roadmap for Sex-Responsive Influenza and COVID-19 Vaccine Research in Older Adults

Shapiro, J. R., Morgan, R., Leng, S. X., & Klein, S. L. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.836642 · Cited by 12

Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis

Yoshifuji, A., Toda, M., Ryuzaki, M., Kikuchi, K., Kawai, T., Sakai, K., Oyama, E., Koinuma, M., Katayama, K., Uehara, Y., et al. (2022) · Renal Replacement Therapy · doi:10.1186/s41100-022-00427-2 · Cited by 11

mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases

Brandi, R., Paganelli, A., D’Amelio, R., Giuliani, P., Lista, F. R., Salemi, S., & Paganelli, R. (2024) · Vaccines · doi:10.3390/vaccines12121418 · Cited by 13

Anaphylaxis to vaccination and polyethylene glycol: a perspective from the European Anaphylaxis Registry

Kraft, M., Renaudin, J. M., Ensina, L. F., Kleinheinz, A., Bilò, M. B., Scherer, K., Dölle‐Bierke, S., & Worm, M. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17327 · Cited by 12

Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021

Lee, E.-J., Lee, Y.-K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., Song, J., Park, Y.-J., Cho, E., & Lee, Y.-K. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.33.2100694 · Cited by 12

Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study

ALMuhizi, F., Fein, M. N., Gabrielli, S., Gilbert, L., Tsoukas, C. M., Ben‐Shoshan, M., Copaescu, A. M., & Isabwe, G. A. C. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.05.014 · Cited by 12

Clinical Development of mRNA Vaccines: Challenges and Opportunities

August, A., Brito, L., Paris, R., & Zaks, T. Z. (2022) · Current topics in microbiology and immunology · doi:10.1007/82_2022_259 · Cited by 12

Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders

Marković, I., Božan, M., Perković, T., Paušek, K., Nedeljković, V., Perković, M., Kelava, T., Artuković, M., & Marković, A. S. (2022) · Medicine · doi:10.1097/md.0000000000029571 · Cited by 12

Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunization Stress-Related Responses With COVID-19 mRNA Vaccine

Imai, K., Tanaka, F., Kawano, S., Esaki, K., Arakawa, J., Nishiyama, T., Seno, S., Hatanaka, K., Sugiura, T., Kodama, Y., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.07.027 · Cited by 12

SARS-CoV-2: Vaccinology and Emerging therapeutics; Challenges and Future Developments

Adesokan, A. M., Obeid, M. A., & Lawal, A. F. (2022) · Therapeutic Delivery · doi:10.4155/tde-2021-0075 · Cited by 12

Drug-induced Anaphylaxis

Torres, M. J., Labella, M., María, R. S. D. S., Bogas, G., Salas, M. L., Fernández, T. D., Mayorga, C., & Doña, I. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221024154951 · Cited by 11

Coronavirus Disease-2019 Vaccine Hesitancy

Hammershaimb, E. A., Campbell, J. D., & O’Leary, S. T. (2022) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2022.12.001 · Cited by 11

What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases

Park, J. K., Lee, E. B., & Winthrop, K. L. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-225492 · Cited by 12

Assessment of potential adverse events following the 2022–2023 seasonal influenza vaccines among U.S. adults aged 65 years and older

Shi, X., Gruber, J. F., Ondari, M., Lloyd, P. C., Duenas, P. F., Clarke, T. C., Nadimpalli, G., Cho, S., Feinberg, L., Hu, M., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.04.051 · Cited by 11

Nanotechnology Approaches for Mitigating Biologic Immunogenicity: A Literature Review

Alanazi, J. S., Aleanizy, F. S., & Alqahtani, F. Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070888 · Cited by 13

Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000

Vieira, J. V. P., Marcelino, J. L. A., Ferreira, F., Farinha, S., Silva, R., Proença, M., & Tomáz, E. (2021) · Asia Pacific Allergy · doi:10.5415/apallergy.2021.11.e18 · Cited by 11

Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong

Chiang, V., Leung, A. S. Y., Au, E. Y. L., Ho, M., Lee, T. H., Wu, A. Y.-Y., Wong, G., & Li, P. H. (2022) · Asia Pacific Allergy · doi:10.5415/apallergy.2022.12.e8 · Cited by 11

Vaccine hesitancy in the post-vaccination COVID-19 era: a machine learning and statistical analysis driven study

Gupta, H., & Verma, O. P. (2022) · Evolutionary Intelligence · doi:10.1007/s12065-022-00704-3 · Cited by 11

Branch retinal vein occlusion post severe acute respiratory syndrome coronavirus 2 vaccination

Tanaka, H., Nagasato, D., Nakakura, S., Nagasawa, T., Wakuda, H., Kurusu, A., Mitamura, Y., & Tabuchi, H. (2022) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo_24_22 · Cited by 11

SARS-CoV-2 and allergy – what have we learned after two and a half years?

Brockow, K., Wang, R., Mathes, S., Bent, R. K., Faihs, V., Eberlein, B., Darsow, U. G., & Biedermann, T. (2023) · Allergologie select · doi:10.5414/alx02373e · Cited by 11

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population

Weinberger, B. (2021) · Vaccines · doi:10.3390/vaccines9121435 · Cited by 11

Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety program

Salmon, D. A., Chen, R. T., BLACK, S. B., & Sharfstein, J. M. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2305707 · Cited by 11

Myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccination: A case report

Kang, M. C., Park, K., Min, J., & Oh, S. Y. (2022) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2022.101620 · Cited by 10

Towards Federated COVID-19 Vaccine Side Effect Prediction

Wang, J., Qian, C., Cui, S., Glass, L. M., & Ma, F. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-26422-1_27 · Cited by 11

Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing

Kohli-Pamnani, A., Zapata, K., Gibson, T., & Kwittken, P. L. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.08.417 · Cited by 9

Subacute thyroiditis with liver dysfunction following coronavirus disease 2019 (COVID-19) vaccination: report of two cases and a literature review

Kishimoto, M., Ishikawa, T., & Odawara, M. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0629 · Cited by 9

Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology

Cesaro, S., Muggeo, P., Zama, D., Cellini, M., Perruccio, K., Colombini, A., Carraro, F., Petris, M. G., Petroni, V., Mascarin, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051235 · Cited by 8

Single cell characteristics of patients with vaccine-related adverse reactions following inactivated COVID-19 vaccination

Jiang, M., Yu, H., Luo, L., Zhang, L., Xiong, A., Wang, J., Wang, Q., Liu, Y. Z., Liu, S., Xiong, Y., et al. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2246542 · Cited by 9

COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices

Wang, Z., Liu, H., Li, Y., Luo, X., Yang, N., Lv, M., Zhou, Q. X., Li, Q., Wang, L., Zhao, J., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.12.015 · Cited by 9

COVID-19: Vaccination Side Effects and Sick Leave in Frontline Healthcare-Workers—A Web-Based Survey in Germany

Nohl, A., Brune, B., Weichert, V., Standl, F., Stang, A., & Dudda, M. (2022) · Vaccines · doi:10.3390/vaccines10030411 · Cited by 8

Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safety

Luo, C., Du, J., Cuker, A. C., Lautenbach, E., Asch, D. A., Poland, G. A., Tao, C., & Chen, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-13809-7 · Cited by 10

Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines

Shavit, R., Segal, R. M., Offengenden, I., Yahia, S. H., Machnes‐Maayan, D., Lifshitz, Y., Niznik, S., Deutch, M., Elbaz, E., Genaim, H., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.08.010 · Cited by 9

Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal

Rayamajhi, S., Rafi, M. A., Tripathi, N., Dongol, A. S., Pandey, M., Rayamajhi, S., Bhandari, S., Shrestha, P., Hasan, M. T., & Hossain, M. G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272729 · Cited by 10

COVID-19: vaccination, therapeutics and a review of the science and public health

Shah, S. K., Bhandari, K., Shah, A., & Chaurasiya, G. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002374 · Cited by 11

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Shimabukuro, T. T., & Nair, N. (2021) · JAMA · doi:10.1001/jama.2021.0600 · Cited by 327

Allergic Reactions to the Pfizer-BioNTech and Moderna COVID-19 Vaccines: Early Reports

Baum, S. G. (2021) · Journal watch · doi:10.1056/nejm-jw.na53087 · Cited by 2

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021

CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7004e1 · Cited by 270

Anaphylaxis to vaccinations: A review of the literature and evaluation of the COVID-19 mRNA vaccinations

Kuder, M. M., Lang, D. M., & Patadia, D. D. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.ccc075 · Cited by 10

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020

CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7002e1 · Cited by 481